BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4027151)

  • 1. Noninvasive assessment of the haemodynamic effects of nicardipine in normotensive subjects.
    Campbell BC; Kelman AW; Hillis WS
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):55S-61S. PubMed ID: 4027151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine.
    Iliopoulou A; Turner P; Warrington SJ
    Br J Clin Pharmacol; 1983 Jan; 15(1):59-65. PubMed ID: 6849746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of nicardipine in acute myocardial infarction.
    Silke B; Verma SP; Hafizullah M; Reynolds G; Frais MA; Jackson NC; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():29-34. PubMed ID: 6527977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
    Jackson NC; Silke B; Verma SP; Reynolds G; Hafizullah M; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():11-6. PubMed ID: 6527973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine.
    Motomura S; Hashimoto K
    Jpn J Pharmacol; 1990 Feb; 52(2):319-30. PubMed ID: 2313939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease.
    Silke B; Verma SP; Nelson GI; Hussain M; Taylor SH
    Br J Clin Pharmacol; 1984 Nov; 18(5):717-24. PubMed ID: 6508981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary and systemic hemodynamic effects of nicardipine.
    Lambert CR; Hill JA; Nichols WW; Feldman RL; Pepine CJ
    Am J Cardiol; 1985 Mar; 55(6):652-6. PubMed ID: 3976506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the haemodynamic effects of nifedipine, nisoldipine and nitrendipine in man.
    Debbas NM; Jackson SH; Turner P
    Eur J Clin Pharmacol; 1986; 30(4):393-7. PubMed ID: 2943594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute haemodynamic effects of oral nicardipine.
    McCredie RM; McKenzie WB; McGill DA
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):163S-168S. PubMed ID: 4027148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular and aldosterone responses to angiotensin II in normal humans: effects of nicardipine.
    Pasanisi F; Elliott HL; Reid JL
    J Cardiovasc Pharmacol; 1985; 7(6):1171-5. PubMed ID: 2418306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog.
    Drieu la Rochelle CD; Grosset A; O'Connor SE
    Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacology of nicardipine in animals.
    Takenaka T; Asano M; Shiono K; Shibasaki M; Inagaki O
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):7S-22S. PubMed ID: 4027153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure.
    Greenbaum RA; Wan S; Evans TR
    Eur J Clin Pharmacol; 1986; 30(4):383-6. PubMed ID: 3743613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
    Pouleur H; Etienne J; Van Mechelen H; Van Eyll C; Charlier AA; Brasseur LA; Rousseau MF
    Postgrad Med J; 1984; 60 Suppl 4():23-8. PubMed ID: 6527976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
    Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
    Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicardipine intravenous bolus dosing for acutely decreasing arterial blood pressure during general anesthesia for cardiac operations: pharmacokinetics, pharmacodynamics, and associated effects on left ventricular function.
    Cheung AT; Guvakov DV; Weiss SJ; Savino JS; Salgo IS; Meng QC
    Anesth Analg; 1999 Nov; 89(5):1116-23. PubMed ID: 10553821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease.
    Rousseau MF; Etienne J; Van Mechelen H; Veriter C; Pouleur H
    J Cardiovasc Pharmacol; 1984; 6(5):833-9. PubMed ID: 6209488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nicardipine on aldosterone release and pressor mechanisms.
    Elliott HL; Pasanisi F; Reid JL
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):99S-102S. PubMed ID: 2992564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
    Visser CA; Jaarsma W; Kan G; Lie KI
    Postgrad Med J; 1984; 60 Suppl 4():17-20. PubMed ID: 6527974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.